Related Experiment Video
Updated: May 25, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Clostridium difficile toxins: mediators of inflammation
1Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vt. 05401, USA. aimee.shen@uvm.edu
Clostridium difficile infections (CDIs) cause severe diarrhea due to toxins TcdA and TcdB. Emerging hypervirulent strains produce more toxins and a third toxin, CDT, increasing disease severity.
Area of Science:
- Microbiology
- Immunology
- Cell Biology
Background:
- Clostridium difficile is a leading cause of hospital-acquired diarrhea globally.
- Infections (CDIs) involve acute intestinal inflammation and neutrophil infiltration.
- Toxins TcdA and TcdB are primary drivers of CDI symptoms.
Purpose of the Study:
- To review the mechanisms of Clostridium difficile toxins.
- To understand how toxins disrupt cell function and host physiology.
- To explore toxin-induced immune responses in CDIs.
Main Methods:
- Literature review of studies on Clostridium difficile toxins.
- Analysis of molecular mechanisms of TcdA, TcdB, and CDT.
- Examination of cellular and host responses to toxins.
Main Results:
- Hypervirulent C. difficile strains overproduce TcdA and TcdB.
- These strains also produce binary toxin (CDT), potentially increasing virulence.
- Both glucosylating toxins and CDT disrupt the actin cytoskeleton.
- Toxins induce severe inflammation and alter host physiology.
Conclusions:
- TcdA, TcdB, and CDT are key virulence factors in Clostridium difficile.
- Understanding toxin mechanisms is crucial for combating severe CDIs.
- Further research into toxin-host interactions can inform therapeutic strategies.
More Related Videos
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Related Concept Videos
Bacterial Toxins
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...